$PSGR Until2017, I am not disagreeing with your post.
$PSGR Until2017, I am not disagreeing with your post. However, you may have misinterpreted mine. I favor the word 'MAY' when writing about Pershing Resources or Investor actions. With that in mind, I may have a different view of WHY the arrangement was made with Don McDowell and HOW it MAY benefit PSGR shareholders. (APRIL 30)
I alluded to the celebrity status of Don McDowell and HOW it MAY be used to attract investors...the analogy of the Sports Celebrity further develops the opportunities that name recognition MAY provide. Unless I am wrong, you seem to question the 'celebrity' of Don McDowell. Check out his association with Rebel Hearts and how extensively the Band has travelled around the World. His NAME is very closely associated with the Band and IN the Country Music World. He may not be a Mega Star like Garth Brooks or Dolly Parton but he (the Band) does have many loyal fans. Among those fans MAY be several dozen zealots who can and will invest in PSGR stock because they will feel an attachment to Don McDowell and/or the Band. (APRIL 30)
You are correct that NOTHING is guaranteed by this association. The only salient point that I wish to share is that there has been NOTHING done for many years that approaches the GAMBLE that Pershing Resources is taking with publicizing the association with Don McDowell. Let's face it: IF everything that Pershing Resources told/shared/posited him turns out to be a load of BS; HE can denounce the company as a sham/scam/joke based upon everything provided to him. You or I do NOT have the clout that he would have IF he PUBLICLY exposed Pershing Resources for less than legal and honest business practices. NOTE: THERE IS NO CURRENT INFORMATION THAT EVEN SUGGESTS THAT PERSHING RSOURCES IS A SHAM/SCAM. Pershing Resources is gambling that it has something of value and Mr. McDowell can develop it and bring it to PROFITABLE PRODUCTIVITY. IF they are trying, in any way, to mislead Mr. McDowell, I am pretty darn certain that the Corporation AND ITS OFFICERS would suffer a large financial burden...at the minimum. (APRIL 30)
For now, as I stated in a prior post, I remain NEUTRAL. After TWENTY PLUS YEARS of NOTHING, I can wait a few more months to see which way this company goes. (APRIL 30)
April 30th is still a major milestone for Pershing Resources that could turn into a Mill Stone that could be tied around the neck of Pershing Resources IF it chooses to BS in deep waters. Of this, I am POSITIVE! (APRIL 30)
Pershing Resources Company Inc. (PSGR) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding TSA PreCheck's Impact on Travelers The latest survey reveals some interesting insights about TSA PreCheck, especially concerning the time savings that members experience at security checkpoints. Conducted by Upgraded Points, this enlightening study assessed the experience of over 1,500 travelers to evaluate the true advantages of holding a TSA PreCheck...
Continue Reading
Intermap Technologies Announces New Prospectus Supplement DENVER – Intermap Technologies Corporation (TSX: IMP; OTCQB: ITMSF), a recognized leader in 3D geospatial products and intelligence solutions, has filed a prospectus supplement in the context of a strategically planned public offering. This initiative signifies a promising step forward, with the company aiming to...
Continue Reading
Critical Deadline for Humacyte Investors Approaches As time runs short, investors in Humacyte, Inc. (NASDAQ: HUMA) should pay attention. Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating claims on behalf of investors who have suffered losses exceeding $75,000 due to potential violations in federal securities laws. Understanding Your...
Continue Reading
Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab Natalie Bartholomew, a highly recognized advocate for women in financial services, will be the featured speaker for the Women in Banking session at Alkami Co:lab 2026. Her expertise and passion are expected to inspire attendees and foster discussions around women's roles in the financial sector. Alkami...
Continue Reading
OPAL Fuels Earnings Report Insights OPAL Fuels OPAL is preparing to release its quarterly earnings report soon, and investors are keenly interested in the results. As the anticipated date for this report approaches, it is essential for investors to stay informed and understand what the expectations are. Projected Earnings Overview Analysts project that OPAL Fuels will...
Continue Reading